Prospective, Post Market Surveillance Q3-registry (POLARIS)

Prospective, Non-randomized Post Market Surveillance Registry to Document the Clinical Performance in Routine Clinical Practice of the POLARIS Peripheral Vascular Self Expanding Stent System.

This is a prospective, non-randomized post market surveillance registry designed to document the clinical Performance in Routine clinical practice of the POLARIS Peripheral Vascular Self Expanding Stent System

Inclusion Criteria:

• Age >18 years
• Single target de novo superficial femoral artery lesion (angiographic evidence of >50% Stenosis or occlusion) by visual estimate
• Rutherford category II-IV
• At least one patent outflow artery to the ankle.
• Patient signed the informed consent

Exclusion Criteria:

• Patient with acute or subacute Thrombus
• Patients with hyperkoagulopathy
• Patients with Stenosis or occlusion where lesion crossing with guide wire is not possible
• Pregnancy or positive pregnancy test
• Previous enrolment in this Trial or other industrial Trials
• Patient´s inability to fully cooperate with the registry protocol Patient with cancer Treatment (life expectancy less than 2 years) Patients with renal failure